|
Index of reports
> Cases resulting in a serious event (47)
> Cases with Breast Cancer (18)
Below is the selection of adverse event reports related to Estratest (Esterified Estrogens) that includes cases resulting in a serious event where reactions include breast cancer.
Adverse event in 48 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in 48 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in 74 year old female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-08
Patient: 74 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Indication: Menopausal Symptoms
Estrace
Indication: Menopausal Symptoms
Estraderm
Indication: Menopausal Symptoms
Estradiol
Indication: Menopausal Symptoms
Estratab
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Ogen
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Prempro
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Adverse event in 74 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-27
Patient: 74 year old female
Adverse reactions / side effects: Abdominal Pain, Narcolepsy, Osteoporosis, Wrist Fracture, Pain, Fall, HIP Surgery, Asterixis, Breast Cosmetic Surgery, Emphysema, Breast Pain, Breast Cancer, Haemorrhoids, Breast Mass, Renal Cyst, Axillary Mass, HIP Fracture, Myoclonus, Dysarthria, Diverticulum, Limb Injury, Radical Mastectomy, Gastrointestinal Disorder, Benign Neoplasm of Thyroid Gland, Arteriosclerosis Coronary Artery, Sleep Apnoea Syndrome, Wrist Surgery
Suspect drug(s):
Combipatch
Indication: Menopausal Symptoms
Start date: 2000-01-01
End date: 2003-01-01
Estratest
Indication: Menopause
Premarin
Provera
Other drugs received by patient: Toprol-XL; Hydrochlorzide; Norvasc; Plaquenil; Allegra; Lipitor
Adverse event in 55 year old female receiving Estratest (Esterified Estrogens)
Reported by a physician from United States on 2007-07-11
Patient: 55 year old female, weighing 62.1 kg (136.6 pounds)
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: hospitalization
Suspect drug(s):
Activella
Indication: Hormone Replacement Therapy
Start date: 2001-06-01
End date: 2002-06-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1999-11-01
End date: 2002-06-01
Prempro
Dosage: 0.625 mg / 2.5 mg
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2001-06-01
Other drugs received by patient: Medroxyprogesterone Acetate; Provera; Estrace; Estring; Serzone; Effexor XR; Xanax
Adverse event in 66 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-10
Patient: 66 year old female, weighing 56.7 kg (124.7 pounds)
Adverse reactions / side effects: Pyrexia, Macrognathia, Vaginal Disorder, Smear Cervix Abnormal, Mammogram Abnormal, Colonic Polyp, Coeliac Disease, Irritable Bowel Syndrome, Bone Density Decreased, Temperature Intolerance, Cough, Breast Cancer, Pneumonia, Vaginal Discharge, Breast Mass, Cataract Operation, Meniere's Disease, Temporomandibular Joint Syndrome, Vision Blurred, Platelet Count Decreased, Gastric Polyps, Lactose Intolerance, Restless Legs Syndrome, Thrombocythaemia, Blood Thyroid Stimulating Hormone Increased, Hepatitis, Hypokalaemia, Pleural Effusion, Genital Disorder Female, Blood Cholesterol Increased, Depression, Injury, Gastrooesophageal Reflux Disease, Loss of Libido, Cataract, Breast Disorder, Hepatic Enzyme Increased, Anxiety, Mucosal Inflammation, Oral Pain, Epigastric Discomfort, Mastectomy, Hypothyroidism, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Aygestin
Combipatch
Indication: Menopause
Start date: 1991-01-01
Combipatch
Dosage: 0.25 mg, unk
Start date: 2000-01-01
End date: 2000-01-01
Estraderm
Dosage: 0.05 mg, unk
Indication: Menopause
Start date: 1994-12-01
End date: 2002-01-01
Estratest
Estrogenic Substance
Ogen
Indication: Menopause
Oragest
Indication: Menopause
Premarin
Premarin
Indication: Menopause
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Prempro
Provera
Dosage: 5 mg for 14 days every other month
Indication: Menopause
Start date: 1995-08-01
End date: 1995-09-01
Vivelle
Dosage: 0.05 mg, unk
Indication: Menopause
Adverse event in 62 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-02
Patient: 62 year old female, weighing 99.8 kg (219.5 pounds)
Adverse reactions / side effects: Polyp Colorectal, Mammogram Abnormal, Fibrocystic Breast Disease, Intervertebral Disc Disorder, Postmenopausal Haemorrhage, Breast Microcalcification, Blood Cholesterol Increased, Benign Breast Neoplasm, Breast Hyperplasia, Breast Cancer, Tonsillectomy, Abscess Drainage, Mastitis, Radiotherapy, Malignant Breast Lump Removal, Appendicitis, Anal Fissure, Haematochezia, Hysterectomy, Uterine Dilation and Curettage, Colonoscopy Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Cycrin
Start date: 1999-01-01
Estrace
Dosage: unk, qhs
Start date: 1999-01-01
Estraderm
Start date: 1989-01-01
Estratest
Start date: 1990-01-01
End date: 1999-01-01
Premarin
Dosage: 0.625 unk, unk
Administration route: Oral
Start date: 1989-01-01
Prempro
Indication: Menopause
Start date: 1999-04-01
End date: 2002-04-01
Provera
Dosage: 10 mg, unk
Start date: 1989-01-01
Other drugs received by patient: Steroids NOS; Oxygen Therapy; Lotrel; Cardizem
Adverse event in 51 year old female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-06-12
Patient: 51 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Climara
Indication: Menopausal Symptoms
Estrace
Indication: Menopausal Symptoms
Estradiol
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Progesterone
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-05-23
Patient: female
Adverse reactions / side effects: Breast Cancer, Oestrogen Receptor Assay Positive, Progesterone Receptor Assay Positive
Suspect drug(s):
Cenestin
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Estring
Indication: Menopausal Symptoms
Femring
Indication: Menopausal Symptoms
Menest
Indication: Menopausal Symptoms
Prometrium
Indication: Menopausal Symptoms
Vagifem
Indication: Menopausal Symptoms
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-05-22
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cenestin
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Estring
Indication: Menopausal Symptoms
Femring
Indication: Menopausal Symptoms
Menest
Indication: Menopausal Symptoms
Prometrium
Indication: Menopausal Symptoms
Vagifem
Indication: Menopausal Symptoms
Adverse event in 59 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-20
Patient: 59 year old female, weighing 59.0 kg (129.7 pounds)
Adverse reactions / side effects: Abdominal Pain, Pain, Rectal Haemorrhage, Endometrial Hypertrophy, Colonic Polyp, Breast Cyst, Fibrocystic Breast Disease, Haemangioma of Liver, Depression Suicidal, Neck Pain, Uterine Leiomyoma, Breast Microcalcification, Breast Cosmetic Surgery, Postmenopausal Haemorrhage, Injury, Exostosis, Radiculopathy, Intervertebral Disc Protrusion, Breast Cancer, Dyspareunia, Spinal Cord Compression, Haemorrhoids, Breast Mass, Radiotherapy, Modified Radical Mastectomy, Suicide Attempt, Spinal Osteoarthritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Estraderm
Dosage: 0.05 mg twice weekly
Indication: Hormone Replacement Therapy
Start date: 1993-08-20
End date: 1997-03-04
Estratest
Dosage: unk, qhs tab
Administration route: Oral
Indication: Menopause
Start date: 1997-04-16
End date: 1997-05-01
MPA
Dosage: unk, qd one tab
Administration route: Oral
Indication: Menopause
Start date: 1993-08-09
End date: 1997-05-01
Premarin
Dosage: 0.625 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1993-08-09
End date: 1993-08-20
Premarin
Dosage: 0.6 unk, unk
Administration route: Topical
Indication: Vulvovaginal Dryness
Start date: 2000-04-07
End date: 2003-03-04
Premphase 14 / 14
Dosage: .625/5 mg/day
Administration route: Oral
Indication: Menopause
Start date: 1996-04-12
End date: 1999-03-10
Prempro
Dosage: 0.625 mg, unk
Administration route: Oral
Indication: Menopause
Start date: 1999-03-10
End date: 1999-07-09
Provera
Dosage: unk, qd, one tab
Administration route: Oral
Indication: Menopause
Start date: 1993-08-09
End date: 1997-05-01
Other drugs received by patient: Prozac; Valium; Evista; Contraceptives NOS
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-06
Patient: female, weighing 51.2 kg (112.7 pounds)
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: hospitalization
Suspect drug(s):
Cenestin
Dosage: .625 mg, unk
Indication: Menopausal Symptoms
Start date: 2002-08-09
End date: 2003-08-01
Estratest
Dosage: .625 mg, unk
Indication: Menopausal Symptoms
Start date: 2002-06-20
End date: 2002-08-09
Estring
Dosage: unknown
Indication: Menopausal Symptoms
Start date: 2001-07-09
End date: 2002-01-01
Estrogen NOS
Dosage: unknown
Indication: Menopausal Symptoms
Femring
Dosage: unk, unk
Indication: Menopausal Symptoms
Start date: 2003-12-15
Menest
Dosage: .3 mg, unk
Indication: Menopausal Symptoms
Start date: 2003-06-18
End date: 2004-01-02
Prometrium
Dosage: 100 mg, unk
Indication: Menopausal Symptoms
Start date: 2002-06-20
End date: 2004-04-15
Vagifem
Dosage: unk, unk
Indication: Menopausal Symptoms
Start date: 2002-01-07
End date: 2003-11-21
Other drugs received by patient: Prosom; Ultram; Wellbutrin
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-04-06
Patient: female
Adverse reactions / side effects: Breast Cancer, Oestrogen Receptor Assay Positive, Progesterone Receptor Assay Positive
Suspect drug(s):
Cenestin
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Estring
Indication: Menopausal Symptoms
Femring
Indication: Menopausal Symptoms
Menest
Indication: Menopausal Symptoms
Prometrium
Indication: Menopausal Symptoms
Vagifem
Indication: Menopausal Symptoms
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-03-20
Patient: female
Adverse reactions / side effects: Breast Cancer, Diabetes Mellitus, Pancreatitis, Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
0.1mg Levonorgestrel / 0.02mg Ethinyl Estradiol / Inert
Depo-Provera
Estratest
Medroxyprogesterone Acetate
Medroxyprogesterone Acetate
Indication: Hormone Replacement Therapy
Premarin
Prempro
Other drugs received by patient: Glucophage; Lopid; Pravachol; Ativan; Ascorbic Acid; Vitamin B Complex CAP; Synthroid
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-03-08
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2003-01-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2003-01-01
Medroxyprogesterone Acetate
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2003-01-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2003-01-01
Prempro
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2003-01-01
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2003-01-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-02-22
Patient: female, weighing 74.8 kg (164.6 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Activella
Dosage: unk, unk
Indication: Menopausal Symptoms
Start date: 2000-11-28
End date: 2001-06-01
Climara
Dosage: .05 mg, unk
Indication: Menopausal Symptoms
Start date: 1997-07-22
End date: 1998-05-01
Estrace
Dosage: 1 mg, unk
Indication: Menopausal Symptoms
Start date: 1992-09-11
End date: 1992-10-01
Estratab
Dosage: .3 mg, unk
Indication: Menopausal Symptoms
Start date: 1998-11-20
End date: 1999-11-01
Estratest
Dosage: unknown
Indication: Menopausal Symptoms
Start date: 1991-12-17
End date: 1992-05-01
Medroxyprogesterone
Dosage: 10 mg, unk
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1995-01-01
Menest
Dosage: .3 mg, unk
Indication: Menopausal Symptoms
Start date: 1999-10-26
End date: 2000-05-01
Ogen
Dosage: 1.25 mg, unk
Indication: Menopausal Symptoms
Start date: 1991-11-15
End date: 1991-12-01
Premarin
Dosage: .9 mg, unk
Indication: Menopausal Symptoms
Start date: 1991-04-10
End date: 1994-11-01
Premarin
Dosage: .625 mg, unk
Start date: 1991-04-10
End date: 1994-11-01
Prempro
Dosage: 0.625/2.5 mg, unk
Indication: Menopausal Symptoms
Start date: 2000-05-10
End date: 2000-11-01
Provera
Dosage: 2.5 - 10 mg, unk
Indication: Menopausal Symptoms
Start date: 1991-04-10
End date: 1999-08-01
Other drugs received by patient: Premarin; Progesterone; Femhrt
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-02-20
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estrace
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Estradiol
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Prempro
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 2003-02-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-01-31
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Estratest
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1999-01-01
End date: 2002-12-01
Femhrt
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1999-01-01
End date: 2002-01-01
Medroxyprogesterone Acetate
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1999-01-01
End date: 2002-12-01
Prefest
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1999-01-01
End date: 2002-12-01
Prempro
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 1999-01-01
End date: 2002-12-01
|
